PROMISE: Functional Test versus tomography for diagnosis of coronary artery disease

This is the first randomized controlled trial to compare the effectiveness of a functional test versus angiography by tomography (≥64 cuts) to diagnose coronary artery disease. The study included 10003 patients from 193 centers who were symptomatic but no previous diagnosis of coronary artery disease.

The study found no difference in prognosis between patients who received a functional test versus those who received angiography so this latter, was established as a valid alternative. The analysis of the radiation dose received and the rate of subsequent studies favored the scan.

Pamela S. Douglas
2015-03-16

Original title: Prospective Multicenter Imaging Study For Chest Pain Evaluation

More articles by this author

REGULATE-PCI: REG1 with an unacceptable rate of severe allergic reactions

The aim of this study was to assess treatment with the new anticoagulant Pegnivacogin and its specific antidote Anivamersen compared with bivalirudin in patients...

PEGASUS-TIMI 54: Ticagrelor plus ASA in stable patients

This double-blind study included 21162 patients with a history of acute myocardial infarction randomized to ticagrelor 90 mg e/12 h, ticagrelor 60 mg e/12...

PARTNER to 5 years. TAVR is an effective alternative to surgery in high risk patients

This study included 699 patients with severe aortic stenosis and high surgical risk of whom 348 received transcatheter aortic valve replacement (TAVR) and 351...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...